A. Jaén

Myelodysplastic syndromes: a study of 101 cases according to the FAB classification

Marta Torrabadella, Antonio Julià, D. Irriguible et al. · British Journal of Haematology · 1985 · 133 citations

Medicine, Hematology, Pathology +16

Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004–05 study

Miguel Martín, Pedro Sánchez‐Rovira, José Manuel Baena-Cañada et al. · Annals of Oncology · 2011 · 34 citations

Medicine, Oncology, Pharmacology +17

Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial.

Pedro Sánchez‐Rovira, A. Jaén, Ignacio Porras et al. · PubMed · 2001 · 24 citations

Medicine, Oncology, Pharmacology +17

Evaluation of a Gemcitabine‐Doxorubicin‐Paclitaxel Combination Schedule through Flow Cytometry Assessment of Apoptosis Extent Induced in Human Breast Cancer Cell Lines

María José Serrano, Pedro Sánchez‐Rovira, Ignacio Algarra et al. · Japanese Journal of Cancer Research · 2002 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

Abnormal chromatin clumping in leucocytes: A clue to a new subtype of myelodysplastic syndrome

A. Jaén, Teresa Vallespı́, Marta Torrabadella et al. · European Journal Of Haematology · 1990 · 18 citations

Medicine, Hematology, Pathology +17